Physician profile
Stephen C Koehler
NPI 1487761433
$1,187.13
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $903 · 2020: $169 · 2021: $44.82 · 2022: $48.95 · 2024: $21.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $21.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $21.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $337.33 | 2019 | |
| Janssen Biotech, INC. | $236.90 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $128.54 | 2019 | |
| Amgen INC. | $96.28 | 2019-2022 | |
| Pfizer INC. | $68.18 | 2019-2022 | |
| Astellas Pharma US INC | $57.01 | 2019-2020 | |
| Genentech USA, INC. | $46.95 | 2019-2020 | |
| Eisai INC. | $32.66 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $32.25 | 2019 | |
| Seagen INC. | $24.41 | 2020 | |
| Janssen Pharmaceuticals, INC | $21.70 | 2024 | |
| Lilly USA, LLC | $21.08 | 2019 | |
| Array Biopharma INC | $18.43 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.11 | 2019 | |
| Incyte Corporation | $16.61 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rigel Pharmaceuticals, INC. | $11.82 | 2019 | |
| Tactile Systems Technology INC | $11.11 | 2019 | |
| Fortovia Therapeutics, INC. | $8.76 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Koehler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.